Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response

BACKGROUND & AIMS: The combination of ledipasvir and sofosbuvir has been approved for treatment of genotype 1 hepatitis C virus (HCV) infection, including an 8-week regimen for treatment-naïve patients without cirrhosis and a baseline level of HCV RNA <6 million IU/mL. We analyzed data from a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gastroenterology
Autors principals: Terrault, Norah A., Zeuzem, Stefan, Di Bisceglie, Adrian M., Lim, Joseph K., Pockros, Paul J., Frazier, Lynn M., Kuo, Alexander, Lok, Anna S., Shiffman, Mitchell L., Ben Ari, Ziv, Akushevich, Lucy, Vainorius, Monika, Sulkowski, Mark S., Fried, Michael W., Nelson, David R.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5300778/
https://ncbi.nlm.nih.gov/pubmed/27565882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2016.08.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars